NewNew: The enterprise guide to Agentic AI — 24 min read.

Read →
Revenue cycle AI

Denials prevented, appeals won and rework capacity returned.

For health system CFOs, revenue cycle and operations leaders. Values prevention and recovery at net reimbursement — not billed charges — so the case survives finance review.

Your inputs

Benchmarks show typical enterprise ranges — override every field with your own numbers.

Benchmark: 500k–3M for a multi-site health system

Collectable amount, not billed charges

Benchmark: $350–$900 depending on payer and service mix

9.5%

Benchmark: 8–12% is the common enterprise band

40%

Coding, eligibility, authorisation and registration errors AI can catch

Benchmark: 30–50% of initial denials

55%

Benchmark: 45–65% on appealed claims

12 pts

Better evidence assembly and payer-specific argument structure

Benchmark: 8–15 points

Benchmark: 25–45 minutes end-to-end

Benchmark: $32–$48 in US health systems

Used to value the working-capital benefit of faster rework

Benchmark: 40–55 days

Annual revenue impact
$33,551,493

Prevented denials, incremental appeal wins, rework capacity returned and the carrying value of faster cash.

Denials prevented at submission53,200 / yr
Additional appeals won9,576 / yr
Rework capacity returned19,152 hrs (10.6 FTE)
Working capital benefit$499,397 at 46d A/R
Simple payback0.3 months
Share & export

Directional estimate. Prevented denials are valued at expected collection, not billed charges. Assumes 45% of denial rework is automatable in the expected case, 3.5 days of A/R recovered at a 6% cost of capital, and a $750k programme investment.

Illustrative estimate only. This calculator models the inputs and assumptions you enter; it is not an audit, valuation, quotation or proposal, and the figures are not a guarantee of results. Actual outcomes depend on scope, data quality, platform configuration and change management. Validate anything material with a Pronix delivery lead before making a decision.

Three-scenario view

Finance reviewers expect a range. These scenarios flex adoption and implementation cost around the model you entered.

Conservative
$22,994,102
0.5 mo payback

Slower adoption, higher integration effort

Base caseYour inputs
$33,551,493
0.3 mo payback

Your inputs as entered

Aggressive
$40,425,997
0.2 mo payback

Strong sponsorship, clean data, phased scale-up

Submit a project brief

Want a quote built on these numbers?

Send us the brief and a delivery lead validates these assumptions against your data, then replies with indicative scope, timeline and commercial options.

CalculatorDenials prevented, appeals won and rework capacity returned. — routed to this team

Prefer to book a slot? →

How enterprise leaders use this model

Where does AI actually reduce denials?
Three places. Pre-submission edits catch coding and eligibility errors before the claim leaves. Denial classification routes the appealable ones to the right worklist instead of a queue. Drafted appeal letters with the clinical evidence attached lift win rates on the ones worth fighting. The first is prevention, the other two are recovery.
Why value write-offs rather than billed charges?
Billed charges overstate everything. A prevented denial is worth its expected collectable amount, and a won appeal is worth the net reimbursement minus the cost of working it. This model uses average reimbursement per claim, not gross charges, so the number survives a CFO review.
What denial rate should we compare against?
Initial denial rates commonly run 8–12% of claims, with roughly two-thirds of denials technically appealable but under half actually appealed because of rework capacity. That gap between appealable and appealed is usually the largest recoverable pool.
How does this affect days in A/R?
Faster classification and drafted appeals shorten the rework cycle, which pulls cash forward. This model values that separately as a working-capital benefit at your cost of capital — it is real, but it is one-time, so it should not be reported as recurring savings.
How this calculator works

What is the ROI of AI in revenue cycle denials management?

Denials AI value is claims corrected before submission so the denial never happens, appeal win-rate lift on those that do, rework capacity returned to the follow-up team, and cash pulled forward through shorter A/R days — all valued at net reimbursement rather than billed charges.

Ungated — results appear instantly, no email required.

What you enter

  • Annual claim volume and denial rate
  • Average net reimbursement per claim
  • Share of denials preventable at submission (%)
  • Current and improved appeal win rate
  • Rework cost per denied claim and A/R days improvement

How it is calculated

  1. 1.Calculate today's denied claim volume and the net revenue exposed.
  2. 2.Apply the pre-submission prevention rate to remove denials at source.
  3. 3.Apply the appeal win-rate lift to remaining denials.
  4. 4.Value rework hours returned at loaded follow-up cost.
  5. 5.Value the A/R days improvement as a working-capital benefit, then subtract investment.

What you get back

  • Net revenue recovered annually
  • Denials prevented and appeals won
  • Rework capacity returned
  • Cash-flow impact from A/R days

Built for: Revenue cycle, finance and RCM operations leaders at health systems and physician groups.

Is preventing a denial worth more than winning an appeal?

Materially more. A prevented denial costs nothing to work and carries no write-off risk, while a won appeal still consumes staff time and delays cash by weeks.

Why value denials at net reimbursement rather than billed charges?

Billed charges are not collectable revenue. Contracted rates, adjustments and payer mix mean net reimbursement is the only figure a CFO will accept in the model.